Log in

NASDAQ:CASICASI Pharmaceuticals SEC Filings & 10K Form

$1.94
+0.03 (+1.57 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.89
Now: $1.94
$2.05
50-Day Range
$1.89
MA: $2.20
$2.58
52-Week Range
$1.15
Now: $1.94
$3.82
Volume766,711 shs
Average Volume306,509 shs
Market Capitalization$234.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.91

SEC Filings

CASI Pharmaceuticals (NASDAQ:CASI) SEC Filings

DateFilerForm TypeView
08/10/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
11:51 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2020
4:16 PM
CASI Pharmaceuticals (Subject)
He Wei-Wu (Filed by)
Form SC 13D/A
07/24/2020
3:05 PM
CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2020
3:05 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2020
3:18 PM
CASI Pharmaceuticals (Filer)
Form 424B5
07/21/2020
3:13 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2020
3:13 PM
CASI Pharmaceuticals (Filer)
Form 424B5
06/18/2020
5:07 AM
CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:05 AM
CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:04 AM
CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:03 AM
CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:02 AM
CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:14 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
4:55 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
2:31 PM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2020
8:45 AM
CASI Pharmaceuticals (Filer)
Form DEF 14A
03/19/2020
4:39 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
2:01 PM
CASI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
10:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
9:01 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
3:51 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
3:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K/A
09/24/2019
3:04 PM
CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:25 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:30 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
10:03 AM
CASI Pharmaceuticals (Filer)
Form CT ORDER
08/15/2019
3:51 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:31 PM
CASI Pharmaceuticals (Filer)
Form 424B5
08/09/2019
9:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:01 PM
CASI Pharmaceuticals (Filer)
Form 424B5
07/19/2019
4:00 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
12:35 PM
CASI Pharmaceuticals (Filer)
Form CT ORDER
05/15/2019
9:03 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:50 PM
CASI Pharmaceuticals (Filer)
Form DEF 14A
04/17/2019
3:03 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
3:01 PM
CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
Form SC 13D/A
04/05/2019
3:31 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
3:02 PM
CASI Pharmaceuticals (Filer)
Form PRE 14A
04/04/2019
6:30 PM
CASI Pharmaceuticals (Issuer)
Spectrum Pharmaceuticals Cayman, L.P. (Reporting)
SPECTRUM PHARMACEUTICALS INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
9:22 AM
CASI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:02 PM
CASI Pharmaceuticals (Filer)
Form NT 10-K
03/13/2019
4:18 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
4:23 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
3:07 PM
CASI Pharmaceuticals (Subject)
Zhejiang Kanglaite Group Co., LTD (Filed by)
Form SC 13G/A
02/06/2019
3:06 PM
CASI Pharmaceuticals (Subject)
Li Dapeng (Filed by)
Form SC 13G
02/06/2019
3:04 PM
CASI Pharmaceuticals (Issuer)
Li Dapeng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2019
6:21 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
6:19 PM
CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:46 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
3:02 PM
CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:00 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:31 PM
CASI Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/06/2018
3:30 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
12:23 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
11:15 PM
CASI Pharmaceuticals (Filer)
Form EFFECT
11/20/2018
4:07 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
3:42 PM
CASI Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2018
9:02 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2018
8:02 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
5:04 AM
CASI Pharmaceuticals (Issuer)
Li Jianguang (Reporting)
Lin Dongliang (Reporting)
Shong Hugo (Reporting)
SNOW MOON LTD (Reporting)
SPARKLE BYTE LTD (Reporting)
TIANJIN JINGRAN MANAGEMENT CENTER (0001664019) (Reporting)
Yang Fei (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2018
5:01 AM
CASI Pharmaceuticals (Subject)
SPARKLE BYTE LTD (Filed by)
Form SC 13D/A
10/31/2018
6:24 PM
CASI Pharmaceuticals (Issuer)
Wealth Strategy Holding Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2018
4:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K/A
10/24/2018
3:57 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2018
3:41 PM
CASI Pharmaceuticals (Subject)
Wealth Strategy Holding Ltd (Filed by)
Form SC 13G/A
10/02/2018
6:20 PM
CASI Pharmaceuticals (Issuer)
Chi George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
6:20 PM
CASI Pharmaceuticals (Issuer)
Chi George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2018
6:19 PM
CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2018
7:13 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
7:13 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
4:26 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
9:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2018
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
11:15 PM
CASI Pharmaceuticals (Filer)
Form EFFECT
08/06/2018
3:28 PM
CASI Pharmaceuticals (Filer)
Form S-3/A
07/17/2018
3:35 PM
CASI Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2018
8:30 PM
CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
2:38 PM
CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
2:38 PM
CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
2:37 PM
CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
2:36 PM
CASI Pharmaceuticals (Issuer)
Wu Alex (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
4:13 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
4:17 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
9:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.